Ruaño, Gualberto

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 , CYP2C19 , CYP2B6 , SLC6A4 , and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants

Bousman, C. A., Stevenson, J. M., Ramsey, L. B., Sangkuhl, K., Hicks, J. K., Strawn, J. R., Singh, A. B., Ruaño, G., Mueller, D. J., Tsermpini, E. E., et al. (2023) · Clinical Pharmacology & Therapeutics

Pharmacogenetics and Drug MetabolismGenetic Associations and Epidemiology

Cited by 521

Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia

Meda, S. A., Ruaño, G., Windemuth, A., O’Neil, K., Berwise, C., Dunn, S. M., Boccaccio, L. E., Narayanan, B., Kocherla, M., Sprooten, E., et al. (2014) · Proceedings of the National Academy of Sciences

Functional Brain Connectivity StudiesSchizophrenia research and treatment

Cited by 242

Mechanisms of statin-induced myalgia assessed by physiogenomic associations

Ruaño, G., Windemuth, A., Wu, A. H. B., Kane, J. P., Malloy, M. J., Pullinger, C. R., Kocherla, M., Bogaard, K., Gordon, B. R., Holford, T. R., et al. (2011) · Atherosclerosis

Pharmacogenetics and Drug MetabolismLipoproteins and Cardiovascular Health

Cited by 66

Length of Psychiatric Hospitalization is Correlated With CYP2D6 Functional Status in Inpatients with Major Depressive Disorder

Ruaño, G., Szarek, B. L., Villagra, D., Gorowski, K., Kocherla, M., Seip, R. L., Goethe, J. W., & Schwartz, H. I. (2013) · Biomarkers in Medicine

Pharmacogenetics and Drug MetabolismTreatment of Major Depression

Cited by 46